New findings out from Yale University suggest autoantibodies — or proteins acting against a person’s own tissues and organs — may correlate with COVID-19 severity and lasting symptoms.
New findings out from Yale University suggest autoantibodies — or proteins acting against a person’s own tissues and organs — may correlate with COVID-19 severity and lasting symptoms.